vs
Side-by-side financial comparison of INTERGROUP CORP (INTG) and Sanara MedTech Inc. (SMTI). Click either name above to swap in a different company.
Sanara MedTech Inc. is the larger business by last-quarter revenue ($27.5M vs $17.3M, roughly 1.6× INTERGROUP CORP). INTERGROUP CORP runs the higher net margin — 8.8% vs -5.9%, a 14.6% gap on every dollar of revenue. On growth, INTERGROUP CORP posted the faster year-over-year revenue change (19.8% vs 4.6%). Sanara MedTech Inc. produced more free cash flow last quarter ($3.9M vs $-481.0K). Over the past eight quarters, Sanara MedTech Inc.'s revenue compounded faster (21.8% CAGR vs 7.8%).
Intergroup Corp is a diversified holding firm operating two core segments: real estate and hotel operations. It owns, manages and leases commercial and residential properties across the U.S., and runs limited-service hotels for leisure and business travelers.
Sanara MedTech Inc. is a US-based medical technology company that develops, manufactures, and distributes innovative surgical, wound care, and post-acute rehabilitation products. It mainly serves healthcare providers, hospitals, and long-term care facilities across North America, with a portfolio of FDA-cleared solutions designed to improve patient outcomes and lower clinical care operational costs.
INTG vs SMTI — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $17.3M | $27.5M |
| Net Profit | $1.5M | $-1.6M |
| Gross Margin | — | 93.2% |
| Operating Margin | 11.6% | 23.5% |
| Net Margin | 8.8% | -5.9% |
| Revenue YoY | 19.8% | 4.6% |
| Net Profit YoY | 155.6% | 5.3% |
| EPS (diluted) | $0.71 | $-0.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $17.3M | $27.5M | ||
| Q3 25 | $17.9M | $26.3M | ||
| Q2 25 | $16.2M | $25.8M | ||
| Q1 25 | $16.8M | $23.4M | ||
| Q4 24 | $14.4M | $26.3M | ||
| Q3 24 | $16.9M | $21.7M | ||
| Q2 24 | $13.4M | $20.2M | ||
| Q1 24 | $14.9M | $18.5M |
| Q4 25 | $1.5M | $-1.6M | ||
| Q3 25 | $-535.0K | $-30.4M | ||
| Q2 25 | $-2.2M | $-2.0M | ||
| Q1 25 | $-578.0K | $-3.5M | ||
| Q4 24 | $-2.7M | $-1.7M | ||
| Q3 24 | $-398.0K | $-2.9M | ||
| Q2 24 | $-4.9M | $-3.5M | ||
| Q1 24 | $-3.2M | $-1.8M |
| Q4 25 | — | 93.2% | ||
| Q3 25 | — | 92.9% | ||
| Q2 25 | — | 92.5% | ||
| Q1 25 | — | 92.2% | ||
| Q4 24 | — | 91.4% | ||
| Q3 24 | — | 90.8% | ||
| Q2 24 | — | 90.0% | ||
| Q1 24 | — | 89.8% |
| Q4 25 | 11.6% | 23.5% | ||
| Q3 25 | 15.3% | 11.2% | ||
| Q2 25 | 8.1% | -0.1% | ||
| Q1 25 | 14.0% | -8.9% | ||
| Q4 24 | 5.9% | 18.6% | ||
| Q3 24 | 18.5% | 3.6% | ||
| Q2 24 | 3.7% | -14.3% | ||
| Q1 24 | 4.8% | -8.3% |
| Q4 25 | 8.8% | -5.9% | ||
| Q3 25 | -3.0% | -115.5% | ||
| Q2 25 | -13.9% | -7.8% | ||
| Q1 25 | -3.4% | -15.1% | ||
| Q4 24 | -18.9% | -6.5% | ||
| Q3 24 | -2.4% | -13.2% | ||
| Q2 24 | -36.7% | -17.4% | ||
| Q1 24 | -21.3% | -9.5% |
| Q4 25 | $0.71 | $-0.32 | ||
| Q3 25 | $-0.25 | $-3.40 | ||
| Q2 25 | — | $-0.23 | ||
| Q1 25 | $-0.27 | $-0.41 | ||
| Q4 24 | $-1.26 | $-0.18 | ||
| Q3 24 | $-0.18 | $-0.34 | ||
| Q2 24 | — | $-0.41 | ||
| Q1 24 | $-1.44 | $-0.21 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $7.5M | $16.6M |
| Total DebtLower is stronger | $233.2M | $46.0M |
| Stockholders' EquityBook value | $-85.2M | $5.9M |
| Total Assets | $101.1M | $72.9M |
| Debt / EquityLower = less leverage | — | 7.74× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $7.5M | $16.6M | ||
| Q3 25 | $6.0M | $14.9M | ||
| Q2 25 | $6.1M | $17.0M | ||
| Q1 25 | $4.8M | $20.7M | ||
| Q4 24 | $15.4M | $15.9M | ||
| Q3 24 | $12.2M | $16.3M | ||
| Q2 24 | $11.6M | $6.2M | ||
| Q1 24 | $19.5M | $2.8M |
| Q4 25 | $233.2M | $46.0M | ||
| Q3 25 | $237.8M | $45.1M | ||
| Q2 25 | $240.5M | $44.2M | ||
| Q1 25 | $241.5M | $43.4M | ||
| Q4 24 | $227.2M | $30.7M | ||
| Q3 24 | $218.1M | $30.1M | ||
| Q2 24 | $225.7M | $14.4M | ||
| Q1 24 | $225.0M | $9.7M |
| Q4 25 | $-85.2M | $5.9M | ||
| Q3 25 | $-86.7M | $6.1M | ||
| Q2 25 | $-86.1M | $35.4M | ||
| Q1 25 | $-84.5M | $36.7M | ||
| Q4 24 | $-83.9M | $39.4M | ||
| Q3 24 | $-80.9M | $39.8M | ||
| Q2 24 | $-80.3M | $41.7M | ||
| Q1 24 | $-76.4M | $43.3M |
| Q4 25 | $101.1M | $72.9M | ||
| Q3 25 | $102.5M | $71.1M | ||
| Q2 25 | $104.1M | $98.8M | ||
| Q1 25 | $103.2M | $96.4M | ||
| Q4 24 | $110.6M | $88.1M | ||
| Q3 24 | $109.3M | $88.5M | ||
| Q2 24 | $107.8M | $73.4M | ||
| Q1 24 | $119.0M | $70.9M |
| Q4 25 | — | 7.74× | ||
| Q3 25 | — | 7.33× | ||
| Q2 25 | — | 1.25× | ||
| Q1 25 | — | 1.18× | ||
| Q4 24 | — | 0.78× | ||
| Q3 24 | — | 0.76× | ||
| Q2 24 | — | 0.34× | ||
| Q1 24 | — | 0.22× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-23.0K | $3.9M |
| Free Cash FlowOCF − Capex | $-481.0K | $3.9M |
| FCF MarginFCF / Revenue | -2.8% | 14.0% |
| Capex IntensityCapex / Revenue | 2.6% | 0.3% |
| Cash ConversionOCF / Net Profit | -0.02× | — |
| TTM Free Cash FlowTrailing 4 quarters | $739.0K | $2.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-23.0K | $3.9M | ||
| Q3 25 | $-296.0K | $2.2M | ||
| Q2 25 | $5.9M | $2.7M | ||
| Q1 25 | $-854.0K | $-2.0M | ||
| Q4 24 | $-781.0K | $932.0K | ||
| Q3 24 | $3.4M | $2.1M | ||
| Q2 24 | $6.8M | $-1.4M | ||
| Q1 24 | $1.9M | $-1.6M |
| Q4 25 | $-481.0K | $3.9M | ||
| Q3 25 | $-1.3M | $1.1M | ||
| Q2 25 | $3.6M | $902.7K | ||
| Q1 25 | $-1.2M | $-3.7M | ||
| Q4 24 | $-1.1M | $859.9K | ||
| Q3 24 | $3.1M | $2.0M | ||
| Q2 24 | $2.7M | $-1.5M | ||
| Q1 24 | $1.1M | $-1.7M |
| Q4 25 | -2.8% | 14.0% | ||
| Q3 25 | -7.1% | 4.2% | ||
| Q2 25 | 22.5% | 3.5% | ||
| Q1 25 | -6.8% | -15.9% | ||
| Q4 24 | -7.8% | 3.3% | ||
| Q3 24 | 18.3% | 9.4% | ||
| Q2 24 | 20.4% | -7.3% | ||
| Q1 24 | 7.6% | -9.0% |
| Q4 25 | 2.6% | 0.3% | ||
| Q3 25 | 5.4% | 4.0% | ||
| Q2 25 | 13.9% | 6.8% | ||
| Q1 25 | 1.8% | 7.4% | ||
| Q4 24 | 2.4% | 0.3% | ||
| Q3 24 | 1.6% | 0.0% | ||
| Q2 24 | 30.4% | 0.3% | ||
| Q1 24 | 4.9% | 0.4% |
| Q4 25 | -0.02× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
INTG
| Hotel Operations | $12.7M | 73% |
| Real Estate Operation | $4.6M | 27% |
SMTI
| Soft Tissue Repair Products | $24.7M | 90% |
| Bone Fusion Products | $2.8M | 10% |
